{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T04:18:35Z","timestamp":1726719515984},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,18]]},"DOI":"10.7759\/cureus.69649","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T13:31:11Z","timestamp":1726666271000},"source":"Crossref","is-referenced-by-count":0,"title":["Pregabalin-Induced Bullous Pemphigoid: A Case Report of a Rare Drug-Triggered Autoimmune Skin Disorder"],"prefix":"10.7759","author":[{"given":"Rachel","family":"Tovar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel T","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramaditya","family":"Srinivasmurthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghana","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liawaty","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00220","article-title":"The growing incidence of bullous pemphigoid: overview and potential explanations","volume":"5","author":"Kridin K","year":"2018","unstructured":"Kridin K, Ludwig RJ. The growing incidence of bullous pemphigoid: overview and potential explanations. Front Med (Lausanne). 2018, 5:220. 10.3389\/fmed.2018.00220","journal-title":"Front Med (Lausanne)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10972","article-title":"Bullous pemphigoid: an immune disorder related to aging (review)","volume":"23","author":"Deotto ML","year":"2022","unstructured":"Deotto ML, Spiller A, Sernicola A, Alaibac M. Bullous pemphigoid: an immune disorder related to aging (review). Exp Ther Med. 2022, 23:50. 10.3892\/etm.2021.10972","journal-title":"Exp Ther Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-017-0264-2","article-title":"Bullous pemphigoid: a review of its diagnosis, associations and treatment","volume":"18","author":"Bernard P","year":"2017","unstructured":"Bernard P, Antonicelli F. Bullous pemphigoid: a review of its diagnosis, associations and treatment\r\n. Am J Clin Dermatol. 2017, 18:513-28. 10.1007\/s40257-017-0264-2","journal-title":"Am J Clin Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10112844","article-title":"Bullous pemphygoid and novel therapeutic approaches","volume":"10","author":"D'Agostino GM","year":"2022","unstructured":"D'Agostino GM, Rizzetto G, Marani A, et al.. Bullous pemphygoid and novel therapeutic approaches. Biomedicines. 2022, 10:2844. 10.3390\/biomedicines10112844","journal-title":"Biomedicines"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-014-0192-0","article-title":"Pregabalin: a review of its use in adults with generalized anxiety disorder","volume":"28","author":"Frampton JE","year":"2014","unstructured":"Frampton JE. Pregabalin: a review of its use in adults with generalized anxiety disorder. CNS Drugs. 2014, 28:835-54. 10.1007\/s40263-014-0192-0","journal-title":"CNS Drugs"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2021.102799","article-title":"A blistering new era for bullous pemphigoid: a scoping review of current therapies, ongoing clinical trials, and future directions","volume":"70","author":"Khalid SN","year":"2021","unstructured":"Khalid SN, Khan ZA, Ali MH, Almas T, Khedro T, Raj Nagarajan V. A blistering new era for bullous pemphigoid: a scoping review of current therapies, ongoing clinical trials, and future directions. Ann Med Surg (Lond). 2021, 70:102799. 10.1016\/j.amsu.2021.102799","journal-title":"Ann Med Surg (Lond)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/03000605241245004","article-title":"Pregabalin-induced delayed cutaneous hypersensitivity reaction occurring after 40 days of use: a case report","volume":"52","author":"Zhang M","year":"2024","unstructured":"Zhang M, Du K, Lu Y, et al.. Pregabalin-induced delayed cutaneous hypersensitivity reaction occurring after 40 days of use: a case report. J Int Med Res. 2024, 52:3000605241245004. 10.1177\/03000605241245004","journal-title":"J Int Med Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3457","article-title":"A systematic review of drug-induced pemphigoid","volume":"100","author":"Verheyden MJ","year":"2020","unstructured":"Verheyden MJ, Bilgic A, Murrell DF. A systematic review of drug-induced pemphigoid. Acta Derm Venereol. 2020, 100:adv00224. 10.2340\/00015555-3457","journal-title":"Acta Derm Venereol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1144429","article-title":"Adaptive and innate immune pathogenesis of bullous pemphigoid: a review","volume":"14","author":"Yan T","year":"2023","unstructured":"Yan T, Zhang Z. Adaptive and innate immune pathogenesis of bullous pemphigoid: a review. Front Immunol. 2023, 14:1144429. 10.3389\/fimmu.2023.1144429","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/2042098613505614","article-title":"Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain","volume":"5","author":"Toth C","year":"2014","unstructured":"Toth C. Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain. Ther Adv Drug Saf. 2014, 5:38-56. 10.1177\/2042098613505614","journal-title":"Ther Adv Drug Saf"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1157250","article-title":"Biological treatment for bullous pemphigoid","volume":"14","author":"Oren-Shabtai M","year":"2023","unstructured":"Oren-Shabtai M, Mimouni D, Nosrati A, Atzmony L, Kaplan B, Barzilai A, Baum S. Biological treatment for bullous pemphigoid. Front Immunol. 2023, 14:1157250. 10.3389\/fimmu.2023.1157250","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11123528","article-title":"Current and innovated managements for autoimmune bullous skin disorders: an overview","volume":"11","author":"Chu KY","year":"2022","unstructured":"Chu KY, Yu HS, Yu S. Current and innovated managements for autoimmune bullous skin disorders: an overview. J Clin Med. 2022, 11:3528. 10.3390\/jcm11123528","journal-title":"J Clin Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/290606-pregabalin-induced-bullous-pemphigoid-a-case-report-of-a-rare-drug-triggered-autoimmune-skin-disorder","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T13:31:13Z","timestamp":1726666273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/290606-pregabalin-induced-bullous-pemphigoid-a-case-report-of-a-rare-drug-triggered-autoimmune-skin-disorder"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.69649","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,18]]}}}